ArticleHealth services research2026
Organizational Perspectives on Access to Care Among Persons With End-Stage Kidney Disease After Enrollment in Medicare Advantage.
Article in Health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo examine Medicare Advantage (MA) plan, dialysis provider organization, and kidney care management company perspectives on how MA enrollment impacts access to care among persons with end-stage kidney disease (ESKD). The 21st Century Cures Act enabled persons with ESKD to enroll in MA, resulting in over 70% growth in enrollment among this group. However, the impact of MA enrollment on access to healthcare and services for people with ESKD remains unknown. STUDY SETTING AND
designThis was a qualitative study that included 48 semistructured interviews with 56 participants representing eight MA plans, six dialysis provider organizations, and five kidney care management companies across all US regions. DATA SOURCES AND ANALYTIC SAMPLE: Interviews were conducted from January 2022 to May 2024. Deductive and inductive coding methods were used and organized around Donabedian's structure-process-outcomes framework. PRINCIPLE
findingsPerspectives diverged by organization and staff type across four themes. Regarding dialysis access, MA plan and large dialysis organization representatives reported no barriers for patients, while small dialysis providers described patients traveling farther to in-network facilities. Concerning specialists, frontline staff reported patients were often unaware of network restrictions limiting access. Regarding transplant, MA plans noted selecting "centers of excellence," while other participants reported these restrictions may be impeding patient access to transplants. For supplementary benefits, executives emphasized their value, while frontline staff reported benefits were often more limited than advertised.
conclusionsParticipant perspectives suggest MA enrollment may differentially impact access depending on dialysis provider size and MA network restrictions. Persons with ESKD may need additional support to make informed insurance enrollment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.